Northera FDA Approval History
FDA Approved: Yes (First approved February 18, 2014)
Brand name: Northera
Generic name: droxidopa
Dosage form: Capsules
Company: Chelsea Therapeutics
Treatment for: Hypotension
Northera (droxidopa) is an orally active synthetic precursor of norepinephrine indicated for the treatment of neurogenic orthostatic hypotension.
Development timeline for Northera
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.